1 / 40

CANCER IN CHILDREN

CANCER IN CHILDREN. KAREN E. MILES FLORIDA GULF COAST UNIVERSITY DEPARTMENT OF NURSING. CHILDHOOD CANCERS BY AGE. SITE 0-5 YR 5-10 YR 10-15 YR Leukemia 39.6* 35.7 22.1 Lymphoma 03.7 13.3 16.4* CNS 15.0 27.1* 18.9 Wilms Tumor 09.2* 06.1 02.0 Neuroblastoma 13.0* 02.2 00.5

billie
Download Presentation

CANCER IN CHILDREN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CANCER IN CHILDREN KAREN E. MILES FLORIDA GULF COAST UNIVERSITY DEPARTMENT OF NURSING

  2. CHILDHOOD CANCERS BY AGE SITE 0-5 YR 5-10 YR 10-15 YR Leukemia 39.6* 35.7 22.1 Lymphoma 03.7 13.3 16.4* CNS 15.0 27.1* 18.9 Wilms Tumor 09.2* 06.1 02.0 Neuroblastoma 13.0* 02.2 00.5 Retinoblastoma 06.4* 01.3 00.0 Bone 00.6 05.0 10.5* Other 08.8 05.8 23.6 *Peak Incidence

  3. INCIDENCE • 14 cases per 100,000 children/yr • 10-25% more common in white than black children

  4. ETIOLOGY • Largely unknown • Most likely - complex interactions of both genetic and environmental factors - Ecogentics

  5. HOST FACTORS • Ataxiatelangectasia - autosomal recessive transmission • Xeroderma Pigmentosum • Immunodeficiency States - 100-fold increased risk, either congenital or acquired • Specific Congenital Anomalies - Down Syndrome (10-18 times greater risk of developing Leukemia)

  6. HOST FACTORS CONT. • Single Gene Defects - 150 associated with development of Cancer (Fanconi Anemia & Bloom Syndrome) • Familial Tendencies - Sibling with Leukemia (4 times greater chance), Monozygous Twins (almost 100% chance)

  7. ENVIRONMENTAL FACTORS • Chemical and Physical Agents - 1) DES 2) Choramphenical, 3) Benzene, 4) Asbestos • Radiation Exposure • Anabolic Androgenic Steriods • Cytotoxic Agents • Immunosuppressive Agents • Viruses - Epstein Barr

  8. PROGNOSIS • 70% will be cured • Children are more responsive to tx and better able to tolerate immediate side effects of surgery

  9. LEUKEMIA • Definition - “White Blood”, Involves blood forming tissues of the bone marrow, spleen, and lymph nodes • Outstanding Characteristic - Abnormal uncontrolled proliferation of one type of wbc • 80-85% of childhood Leukemias are Acute Lymphocytic Leukemia (ALL)

  10. INCIDENCE • 4 per 100,000 children per year • Peak Incidence - Between 2-6 years • Twice as common in white children as non-white • More common in males

  11. CLASSIFICATION • Acute or Chronic • Cell Line - Lymphoid or Myeloid Cells • FAB Cooperative Group Classification - Based on histologic appearance of abnormal lymphoblast - 85% - L1, 15% - L2, less than 1% - L3

  12. CLASSIFICATION CONT. Immunologic Classification - based on certain surface cell antigens • T- Cell - common in older boys • B- Cell - Poor Prognosis • Pre B- Cell • Early Pre B- Cell (Null Cell) • Common Acute Lymphoblastic Leukemia Antigen (CALLA)

  13. BEST PROGNOSIS • ALL 1 • Early Pre B- Cell • CALLA Positive

  14. CLINICAL MANIFESTATIONS • Onset - Abrupt or Insidious • Common Symptoms Reflect Bone Marrow Failure - Decreased rbcs, decreased platelets, and changes in wbcs • Pallor, fatigue, petechiae, purpura, bleeding and fever • WBC Count of less than 10,000/mm3

  15. CLINICAL MANIF. CONT. • Renal Failure because of high uric acid levels - Give Allopurinal • Extramedullary invasion of Leukemic cells CNS most common site MOST have at diagnosis

  16. CLINICAL MANIF. CONT. • Infiltration into bones and joints • Infiltration of other organ sites: kidneys, heart, eyes, skill and GI tract

  17. EVALUATION • Peripheral smear • Blast Cell hallmark of acute leukemia • Normal - less than 5% blast cells in bone marrow and none in peripheral blood • With ALL the bone marrow may be replaced by 80-100% blast cells

  18. TREATMENT FOUR PHASE TREATMENT PROGRAM • Induction Phase - Goal is no clinical evidence of disease and normal bone marrow. 95% in 4-6 weeks • Intensification (Sanctuary) Therapy • Prophylactic Therapy for the CNS • Maintenance Therapy - Usually 3 years

  19. PROGNOSIS • ALL IS CURABLE • Overall - 60-70% • ALL1, Pre- B Cell, CALLA Positive - 90%

  20. LYMPHOMAS Non - Hodgkin Lymphoma • Two Types - Nodular (Adults) and Diffuse (Child) • Affects 7 to 8 children per 1 million • Rapidly progressive with enlarging lymphoid tissue and painless lymphadenopathy

  21. LYMPHOMAS CONT. • Most frequent site - Abdomen • Treatment - Biopsy, combination chemotherapy and radiation • 60-80% can be cured

  22. HODGKIN DISEASE • Affects about 5 in 1 million children • Mostly Adolescents • Characterized by painless enlargement of lymph nodes • Presence of Sternberg-Reed cell • Treatment Modalities - Irradiation and chemotherapy • 90% 10 year survival rate with localized disease

  23. BRAIN TUMORS • Incidence - 2.4 per 100,000 • Cause Unknown • CLASSIFICATION - Most arise from glial tissue, the supportive tissue of the brain • 60% are INFRATENTORIAL - Occur in the posterior third of the brain

  24. TYPES Cerebellar Astrocytomas • Most common Type • Benign, Cystic, Slow-growing • 95% cure rate with surgical excision

  25. TYPES CONT. Medulloblastomas • Fast growing • Highly malignant • Cerebellum most common site • 40% survival rate

  26. TYPES CONT. Brainstem Gliomas • Slow growing • astrocytomas or glioblastomas • Radiation may shrink tumor

  27. TYPES CONT. Ependymomas • Varying speed of growth • Freq. occur in the 4th Ventricle which leads to CSF Obstruction • Close to vital centers • Chemotherapy and radiation

  28. NEUROBLASTOMA • Definition - Embryonal Tumor of neural crest cells that normally give rise to the sympathetic ganglia and adrenal medulla • Tumor of young children • Silent tumor - 70% have metastatic disease at diagnosis • Primary Site - Addomen

  29. RETINOBLASTOMA • Definition - Rare congenital tumor that originates in the retina of one or both eyes • 200 children a year in the US • 2 forms - Inherited - Diagnosed during first year and often involves both eyes, and Aquired - Diagnosed 2-3 years and 60% unilateral

  30. RETINOBLASTOMA CONT. • Primary Sign - LEUKOKORIA, a white pupillary reflex called “cat’s eye reflex”. Others - strabismus, red, painful eye, and limited vision • Treatment - radiation for small tumors, large or multiple tumors require enucleation • Prognosis - 90% long term survival rate

  31. WILMS TUMOR • Definition - Embryonal tumor of the kidney, Nephroblastoma • Incidence - 7.8 cases per 1 million children. Approximately 400 children diagnosed each year or 1 per 10,000 children • Pathogenesis - 2 forms - Sporadic - No known genetic predisposition and Inherited -Autosomal Dominant Transmission

  32. WILMS TUMOR CONT. • Both forms linked to the deletion or inactivation of genes on the short arm of Chromosome #11 • 18% of children with Wilms have other congenital anomalies

  33. WILMS CONT. • Clinical Manifestations - 90% have enlarging asymptomatic upper abdominal mass that is firm, nontender, smooth, and encapsulated • Treatment - Nephrectomy. Radiation (except in Stage I & II ), Chemotherapy. • Prognosis - 95% cure rate for Stage I to III

  34. RHABDOMYOSARCOMA • Definition - Soft tissue sarcoma that arises from undifferentiated mesenchymal cells in muscle, tendons, bursae, and fascia, or fibrous, connective, lymphatic or vascular tissue • Two thirds diagnosed by 10 years of age • Many sites - head and neck most common

  35. RHABDOMYOSARCOMA • Treatment - Combination surgery, radiation and chemotherapy • Prognosis - Long term survival rate 70-80%

  36. NURSING CARE OF CHILDWITH LEUKEMIA Prepare Child & Family for Diagnostic and Therapeutic Procedures • Bone Marrow Aspiration (W & W -pg. 1252) • Lumbar Puncture (W & W - pg. 1251) • Placement of Central Catheter (W& W - pg. 1308-1311) Boviac Hickman Infus-A-Port

  37. PREVENT COMPLICATIONS OF MYELOSUPPRESSION • Infection Goal is prevention • Hemorrhage Platelet Count less than 20,000/mm Epistaxis and Gingival • Anemia Transfusions

  38. MANAGE PROBLEMS OF IREADIATION AND DRUG THERAPY • Nausea and Vomiting • Anorexia • Mucosal Ulceration • Neuropathy • Hemorrhagic Cystitis • Alopecia • Moon Face

  39. RELIVE PAIN • Analgesics • Positioning • Decrease Environmental Stimuli

  40. PROVIDE ADEQUATE FAMILY SUPPORT • Explain tests and procedures honestly • Schedule uninterrupted family time • Encourage family to discuss feelings and concerns • Encourage active family participation in care

More Related